| Financial Year |
March 31 2023 |
| Monetary Funds |
372,575,805.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
116,674,035.36 |
| Advances to Suppliers |
37,948.24 |
| Other Receivables |
40,562,360.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
436,469,011.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,948,282.89 |
| Total Current Assets |
973,267,444.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
802,655,477.77 |
| Under-construction Projects |
85,365,700.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,804,149.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,991,863.29 |
| Deferred Income Tax Assets |
14,414,163.66 |
| Other Non-Current Assets |
44,204,107.24 |
| Sub-Total of Non-Current Assets |
1,043,798,025.79 |
| Total Assets |
2,017,065,469.89 |
| Short-Term Loans |
372,275,855.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
74,315,000.00 |
| Accounts Payable |
198,449,867.80 |
| Accounts Received In Advance |
966,826.11 |
| Employee Compensation Payable |
27,051,463.25 |
| Taxes Payable |
9,754,991.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,025,609.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,763,471.96 |
| Other Current Liabilities |
900,446.72 |
| Sub-Total of Current Liabilities |
790,398,213.06 |
| Long-term Loans |
29,295,699.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,036,166.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,597,771.57 |
| Total Liabilities |
858,995,984.63 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
612,256,981.69 |
| Surplus Reserve |
16,030,928.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
329,781,574.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,158,069,485.26 |
| Owner's Equity（Stockholder's Equity） |
1,158,069,485.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,017,065,469.89 |
